News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts

Spotlight -

Downstream Processing|

Upstream Processing

|Articles|July 1, 2015

Collaborative Success Strategies for Biopharm Companies

Barry Holtz, Principal, at Holtz Biopharma Consulting, and Klyo Collaborative, spoke with BioPharm International about collaborative success strategies for biopharm companies.

Barry Holtz, Principal, at Holtz Biopharma Consulting, and Klyo Collaborative, spoke with BioPharm International about collaborative success strategies for biopharm companies.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Content

idea, light bulb, rocket, innovation, technology, business, development, imagination, inspiration, intelligence, hand hold light bulb to light up solution and advertise hit the goal and target rocket. | Image credit: © Garun Studios - stock.adobe.com

New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy

ByFeliza Mirasol

January 22nd 2026

Male Engineers Maintenance Robot Arm at Lab. he are in a High Tech Research Laboratory with Modern Equipment. Technology and Innovation Concept.Professional. | Image credit: © anon - © anon - stock.adobe.com

High-Throughput Systems Refine Protein Engineering

ByFeliza Mirasol

January 22nd 2026

Scaling RNA therapeutics sustainably using the ECO Synthesis Manufacturing Platform

Scaling RNA therapeutics sustainably using the ECO Synthesis Manufacturing Platform

January 22nd 2026

Single helix RNA, Epigenetics concept | Image credit: © Artur - © Artur - stock.adobe.com

European Approval of Donidalorsen Expands RNA-Targeted Prevention Strategies for HAE

ByFeliza Mirasol

January 21st 2026

Bispecific antibody colored heavy chain in green and pink, light chain blue and yellow against gray background; glycosylated bispecific immunoglobulin engineered to target different antigens 3d render | Image credit: © huenstructurebio.com - © huenstructurebio.com - stock.adobe.com

Next-Generation Modalities Drive New Antibody Discovery

ByFeliza Mirasol

January 21st 2026

Trending on BioPharm International

Next-Generation Modalities Drive New Antibody Discovery

New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy

European Approval of Donidalorsen Expands RNA-Targeted Prevention Strategies for HAE

GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies

State of the Bio/Pharma Workforce: A Comparative Analysis of Employment Trends and Industry Sentiment